Quick Answer
Nuvalent, Inc. reported Diluted EPS of $5.85 per share (loss) for fiscal year 2025.
Nuvalent, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$5.85 | -48.9% |
| 2024 | -$3.93 | -81.1% |
| 2023 | -$2.17 | -31.5% |
| 2022 | -$1.65 | +22.5% |
| 2021 | -$2.13 | +58.1% |
| 2020 | -$5.08 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.70 | -32.8% | -22.3% |
| June 30, 2025 | -$1.39 | -58.0% | -17.8% |
| March 31, 2025 | -$1.18 | -71.0% | +7.8% |
| September 30, 2024 | -$1.28 | -116.9% | -45.5% |
| June 30, 2024 | -$0.88 | -72.5% | -27.5% |
| March 31, 2024 | -$0.69 | -56.8% | -16.9% |
| September 30, 2023 | -$0.59 | -43.9% | -15.7% |
| June 30, 2023 | -$0.51 | -34.2% | -15.9% |
- Nuvalent, Inc. showed a decrease of -48.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Nuvalent, Inc.’s diluted eps has declined by 15.2% (from $5.08 per share (loss) to $5.85 per share (loss)).
- The most recent figure is from Nuvalent, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: